Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
2638995018 | Prednisolone sodium phosphate + sulfacetamide sodium 2.5mg/100mg solution (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
2642975017 | Prednisolone sodium phosphate + sulfacetamide sodium 2.5mg/100mg solution | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3267641000052110 | prednisolonnatriumfosfat 2,5 mg + natriumsulfacetamid 100 mg, lösning | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
prednisolonnatriumfosfat 2,5 mg + natriumsulfacetamid 100 mg, lösning | Is a | Product containing sulfacetamide (medicinal product) | false | Inferred relationship | Some | ||
prednisolonnatriumfosfat 2,5 mg + natriumsulfacetamid 100 mg, lösning | Is a | Product containing prednisolone (medicinal product) | false | Inferred relationship | Some | ||
prednisolonnatriumfosfat 2,5 mg + natriumsulfacetamid 100 mg, lösning | Is a | Product containing prednisolone in ocular dose form (medicinal product form) | false | Inferred relationship | Some | ||
prednisolonnatriumfosfat 2,5 mg + natriumsulfacetamid 100 mg, lösning | Has active ingredient | Sulfacetamide (substance) | false | Inferred relationship | Some | ||
prednisolonnatriumfosfat 2,5 mg + natriumsulfacetamid 100 mg, lösning | Has active ingredient | Prednisolone ophthalmic preparation | false | Inferred relationship | Some | ||
prednisolonnatriumfosfat 2,5 mg + natriumsulfacetamid 100 mg, lösning | Has active ingredient | Prednisolone sodium phosphate | false | Inferred relationship | Some | ||
prednisolonnatriumfosfat 2,5 mg + natriumsulfacetamid 100 mg, lösning | Has active ingredient | Corticosterone | false | Inferred relationship | Some | ||
prednisolonnatriumfosfat 2,5 mg + natriumsulfacetamid 100 mg, lösning | Has active ingredient | Sulfacetamide sodium | false | Inferred relationship | Some | ||
prednisolonnatriumfosfat 2,5 mg + natriumsulfacetamid 100 mg, lösning | Has active ingredient | binjurehormonmedel | false | Inferred relationship | Some | ||
prednisolonnatriumfosfat 2,5 mg + natriumsulfacetamid 100 mg, lösning | Is a | prednisolonnatriumfosfat | false | Inferred relationship | Some | ||
prednisolonnatriumfosfat 2,5 mg + natriumsulfacetamid 100 mg, lösning | Has active ingredient | Glucocorticoid hormone | false | Inferred relationship | Some | ||
prednisolonnatriumfosfat 2,5 mg + natriumsulfacetamid 100 mg, lösning | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
prednisolonnatriumfosfat 2,5 mg + natriumsulfacetamid 100 mg, lösning | Is a | prednisolonacetat + natriumsulfacetamid | false | Inferred relationship | Some | ||
prednisolonnatriumfosfat 2,5 mg + natriumsulfacetamid 100 mg, lösning | Has active ingredient | Prednisolone acetate | false | Inferred relationship | Some | ||
prednisolonnatriumfosfat 2,5 mg + natriumsulfacetamid 100 mg, lösning | Has manufactured dose form | Ocular dose form (dose form) | false | Inferred relationship | Some | ||
prednisolonnatriumfosfat 2,5 mg + natriumsulfacetamid 100 mg, lösning | Is a | sulfacetamid för oftalmiskt bruk | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set